Literature DB >> 12972459

Phospholipid transfer protein and atherosclerosis.

Alan R Tall, Florent Lalanne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12972459     DOI： 10.1161/01.ATV.0000089080.76134.CE

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  4 in total

1.  Identification and characterization of dual inhibitors for phospholipid transfer protein and microsomal triglyceride transfer protein.

Authors:  Yi Luo; Lorraine Shelly; Thomas Sand; George Chang; Xian-Cheng Jiang
Journal:  J Pharmacol Exp Ther       Date:  2010-08-30       Impact factor: 4.030

2.  Pharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein-B secretion from hepatocytes.

Authors:  Yi Luo; Lorraine Shelly; Thomas Sand; Benjamin Reidich; George Chang; Mary Macdougall; Marie-Claire Peakman; Xian-Cheng Jiang
Journal:  J Pharmacol Exp Ther       Date:  2009-11-20       Impact factor: 4.030

3.  Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes.

Authors:  Axel Schlitt; Bernhard Schwaab; Kirsten Fingscheidt; Karl J Lackner; Gunnar H Heine; Alexander Vogt; Michael Buerke; Lars Maegdefessel; Uwe Raaz; Karl Werdan; Xian-Cheng Jiang
Journal:  Lipids       Date:  2010-01-27       Impact factor: 1.880

4.  Haptoglobin inhibits phospholipid transfer protein activity in hyperlipidemic human plasma.

Authors:  Ryan J Henderson; Kishor M Wasan; Carlos G Leon
Journal:  Lipids Health Dis       Date:  2009-07-23       Impact factor: 3.876
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.